US FDA Role In Biomanufacturing Initiative Largely Packages Ongoing Works

 
• By Michael McCaughan

The White House ‘Biotechnology’ initiative is very broadly focused, with non-health sectors receiving the bulk of the attention. The US FDA’s role is small – but it could further boost attention to efforts to encourage adoption of advanced manufacturing.

Made in USA pills
• Source: Shutterstock

The US Department of Health & Human Services is pledging $40 million to support biotech manufacturing of medicines as part of the implementation process for President Biden’s Executive Order launching a National Biotechnology & Biomanufacturing Initiative.

As part of its

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Manufacturing

More from Compliance